16:08 EDT Mirum Pharmaceuticals (MIRM) files automatic mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIRM:
- Arm initiated, Adobe downgraded: Wall Street’s top analyst calls
- Mirum Pharmaceuticals resumed with a Buy at Stifel
- Mirum Pharmaceuticals: Strong Buy Rating Backed by Robust Growth Prospects in Rare Disease Market
- Buy Rating Affirmed for Mirum Pharmaceuticals Amid Strong Financial Performance and Growth Potential
- Mirum Pharmaceuticals Reports Strong Q2 Growth and Raises Guidance